World of DTC Marketing

JANUARY 20, 2022

and recent privacy regulations. She feels reassured by advice that matches what she already knew about a condition and by repeated statements at more than one site. Pharma has historically focused a significant portion of its marketing budgets on paid search.

Digital Media 232

Digital Media Media Pharma Doctors 232

PM360

JULY 26, 2023

Even top AI developers from Google and OpenAI co-signed a statement at the end of May from non-profit the Center for AI Safety that said, “Mitigating the risk of extinction from AI should be a global priority alongside other societal-scale risks such as pandemics and nuclear war.” Europe has a pretty significant advantage right now with GDPR.

Government 95

Government Marketing Management Education 95

pharmaphorum

DECEMBER 29, 2022

I support the initiative of simplifying data privacy and the idea of making it more accessible, yet, there are some real challenges the Bill poses for organisations wishing to act from beyond the realms of the UK. However, in practice there are some fundamental issues with what is being proposed in the Bill.

Government 92

Government Management Pharma Leads 92

eatNgage

FEBRUARY 15, 2022

This statement rings true when it comes to closing business deals. Make it memorable. There’s a saying that goes, “People will forget what you said. People will forget what you did. But people will never forget how you made them feel”. It’s a memorable experience, to say the least. Click here to learn more. Useful Links. Partners Program.

Sales pitches 52

Sales pitches Sales B2B Sales Prospecting 52

pharmaphorum

DECEMBER 15, 2022

They are experts at providing clear and concise scientific communication through the virtual medium, all while having the professional credentials and credibility to back up their statements. During conferences and congresses, you’ll typically find DOLs live-Tweeting about the different sessions, abstracts, and posters. Connecting peers.

Media 83

Media Healthcare Healthcare Education 83

Impetus Digital

JANUARY 3, 2023

They are experts at providing clear and concise scientific communication through the virtual medium, all while having the professional credentials and credibility to back up their statements. However, there are obvious privacy concerns with this approach to networking. Connecting Peers.

Media 52

Media Healthcare Healthcare Recruitment 52

pharmaphorum

NOVEMBER 28, 2022

“Innovation thrives in collaboration, not in isolation – and the open sourcing of Substra is a landmark moment in the use of collaborative AI in medical research,” Ibrahim Haddad, general manager of the LF AI & Data Foundation, said in a statement. Open source is undoubtedly the future of AI research.”.

Training 72

Training Medical Pharma Healthcare 72

pharmaphorum

NOVEMBER 28, 2022

The US Department of Health and Human Services issued a new proposed rule Monday that would change how privacy protections for people with substance abuse disorders interact with HIPAA information sharing rules. The post New HHS rule would harmonise substance abuse privacy rule, HIPAA appeared first on.

Patients 52

Patients Healthcare Provider Government Education 52

Copyright Clearance Center

JANUARY 31, 2023

The complaint includes a statement by GitHub asserting an expansive, almost global fair use assertion which is at odds with explicit relevant law in many countries and frankly at odds even with US law. Also sued were a confusing mishmash of for profit and non-profit related entities all using a variation of the name OpenAI (OpenAI, Inc.,

Distribution 98

Distribution Engineering Competition Training 98

Pharmaceutical Technology

MAY 22, 2023

In an August 2022 statement , Moderna stated its technology contained within patents filed between 2010 and 2016 was copied without permission. CureVac’s lawsuits add to a complex legal landscape for Pfizer/BioNTech that already includes ones from Moderna. Pfizer/BioNTech then countersued in December 2022.

Biopharma 116

Biopharma Prospecting Competition Pharmaceutical 116

Pharmaceutical Technology

JUNE 2, 2023

Broader coverage will begin on the day of the drug’s traditional approval, when it comes through, and CMS’ proposed method will aim to collect more real-world evidence on the drug’s use, as per the 1 June statement. upon its widespread use. Clinical investigators commonly use registries to gather information on patient outcomes.

Food and Drug Administration 52

Food and Drug Administration FDA Prospecting Food 52

Pharmaceutical Technology

APRIL 21, 2023

Emergent Biosolutions, maker of the opioid overdose reversing nasal spray Narcan, intends to price the treatment at less than $50 for a kit of two 4mg doses for over-the-counter use (OTC) the company said in a statement. While justifying the price, the Emergent statement said the company needs to “foster a sustainable business model”.

Food and Drug Administration 52

Food and Drug Administration Retail Prescription Management 52

Pharmaceutical Technology

MAY 10, 2023

The British charitable organisation, the Migraine Trust released a statement welcoming the SMC’s decision. Furthermore, a statement from the charity said the drug may help those with contraindications or an inadequate response to the standard of care for migraine treatment—triptans. Vydura is also sold under the brand name Nurtec.

Medicine 52

Medicine Prospecting Medical Competition 52

Pharmaceutical Technology

MAY 9, 2023

In a statement released after the CMS’s initial decision to not cover Alzheimer’s Association statement, the non-profit organisation said, “For CMS to treat those with Alzheimer’s differently than those with other diseases is unprecedented and unacceptable.”

FDA 52

FDA Prospecting Patients Marketing 52

Pharmaceutical Technology

MAY 9, 2023

In a statement released after the CMS’s initial decision to not cover Alzheimer’s Association statement, the non-profit organisation said, “For CMS to treat those with Alzheimer’s differently than those with other diseases is unprecedented and unacceptable.”

FDA 52

FDA Prospecting Patients Marketing 52

Pharmaceutical Technology

JUNE 1, 2023

A statement from the company highlighted frexalimab’s mechanism of action of blocking the CD40/CD40L costimulatory pathway, as one that potentially regulates both adaptive and innate immune cell activation and function, which is pivotal in the pathogenesis of MS.

Marketing 64

Marketing Patients Prospecting Competition 64

Pharmaceutical Technology

JUNE 20, 2023

In a 20 June statement , he said the deal would “[enhance] our efforts to make life better for people living with devastating autoimmune diseases”. At $48 a share for the South San Francisco,California-based biopharma, Lilly is paying a 40% premium on top of the 30-day average trading price.

Prospecting 52

Prospecting Competition Biopharma Marketing 52

Pharmaceutical Technology

MAY 31, 2023

In its statement, the FDA cited research that says medication nonadherence can cause almost 25% of hospital admissions, 50% of treatment failures, and approximately 125,000 US deaths annually.

Prescription 52

Prescription FDA Food and Drug Administration Medical 52

Pharmaceutical Technology

MAY 5, 2023

Previously, ABPI released a statement expressing concerns that the current voluntary scheme may not be fit for purpose in a post-pandemic environment. The two schemes are designed to be complementary and make up total medicine costs by requiring pharmaceutical companies to make clawback payments.

Government 52

Government Medicine Medical sales Pharmaceutical 52

Pharmaceutical Technology

DECEMBER 22, 2022

JCA reports will not give statements that may imply and predetermine national reimbursement decisions and will not have a legally binding effect, meaning national HTA bodies are welcome to draw their own conclusions on the clinical added value of the new medicine.

Medicine 52

Medicine Pharma Marketing Distribution 52

Pharmaceutical Technology

JUNE 20, 2023

F2G claimed in a June statement that the FDA requested additional data and analysis that extended beyond the current review period. The company was seeking approval for Olorofim, an investigational antifungal intended to treat invasive fungal infections in patients with limited treatment options.

FDA 52

FDA Prospecting Patients Competition 52

Pharmaceutical Technology

JUNE 15, 2023

In a 15 June statement, Sandoz said that it hoped the Act4Biosimilars action plan will provide actionable solutions to overcome barriers preventing patient access to biosimilars. Generic and biosimilar pharmaceutical company and Novartis subsidiary Sandoz announced its plan to accelerate patient access to biosimilars.

Education 52

Education Patients Healthcare Healthcare 52

Pharmaceutical Technology

MAY 18, 2023

The DeTAP trial clearly demonstrates how using digital technology can increase and speed up clinical trial recruitment while also keeping the participant fully engaged.

Recruitment 52

Recruitment Food and Drug Administration Patients Media 52

Pharmaceutical Technology

JUNE 19, 2023

In a June statement, Rosemont CEO Howard Taylor highlighted Lucis’ product pipelines and developer relationships as a driver of the acquisition, accelerating Rosemont’s entry into the sachet market.

Medicine 52

Medicine Manufacturing Marketing Pharmaceutical 52